Guangdong Biolight Meditech (300246.SZ) announced on August 5th that the company has recently received a Medical Instrument Registration Certificate from the China National Medical Products Administration (NMPA) for their blood dialyzer product with the product name Blood Dialyzer.
The membrane material of the blood dialyzer certified this time uses polyethersulfone fiber membrane, which is a high-flux blood dialyzer. Previously, the company had already obtained a Medical Instrument Registration Certificate for a low-flux blood dialyzer, and a holding subsidiary, Suzhou Jinkang, had obtained Medical Instrument Registration Certificate for high-flux and low-flux blood dialyzers independently developed and produced. This certification has enriched the product category of the company's blood purification products in terms of multi-brand, differentiated competition, global sales, and provided more choices for medical staff and patients, which will increase the company's competitiveness in the field of blood purification. In the future, the company will make full use of its independent advantages, technology, quality, and scale of the group, and strive to become the industry leader in the domestic blood purification field across the entire industry chain.